CABG trumps PCI for mortality in diabetes patients

Eight-year follow-up in patients with multivessel coronary disease

Long-term follow-up of patients with diabetes and multivessel coronary disease shows coronary-artery-bypass grafting (CABG) is more effective at extending life than percutaneous coronary intervention with drug-eluting stents (PCI-DES).

The findings come from the FREEDOM trial of 1,900 patients - of which 83% had three-vessel disease -  who were randomised to be managed with drug-eluting stents with sirolimus or paclitaxel or with CABG. 

The researchers reported there were 204 deaths during the original trial and